Bilinsky Igor

Avg. Two Year Performance

(74%) Avg. Purchase Return
(32%) Compound
70% Avg. Sale Return
30% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(8%)(17%)(16%)(19%)(74%)
Purchase Success Rate0 of 10 of 10 of 10 of 10 of 1
Average Sale Return7%12%22%53%70%
Sale Success Rate5 of 76 of 77 of 77 of 77 of 7
Drugs » Biotechnology

Chief Business Officer:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Chief Operating Officer:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Chief Operating Officer:

Holdings: 55.81K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Sr VP, Corporate Development:

Holdings: 193.8K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

GM, Immuno-Oncology/SVP Sp Ops:

Holdings: 6.96K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--